Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

C22orf9_5031439G07Rik Inhibitors

C22orf9 is a protein that is encoded by the C22orf9 gene, situated on the 22nd chromosome in humans. The specific functions and roles of C22orf9 remain largely undefined, and as such, it is designated as an open reading frame (orf), indicating that it is a segment of DNA that has been identified to potentially code for a protein but whose function is not yet clear.The research on proteins like C22orf9 typically involves a combination of bioinformatics approaches to predict protein structure and function, and experimental verification to confirm these predictions and to identify the protein's role in the cell. Such studies might explore the protein's expression patterns across different tissues and developmental stages, its subcellular localization, and its interactions with other proteins.The study of C22orf9 may reveal its participation in specific cellular pathways or processes, such as signal transduction, gene regulation, or metabolic pathways. It is also possible that C22orf9 could be implicated in disease processes if mutations or alterations in its expression are discovered to be associated with particular pathologies.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR signaling, which can impact protein synthesis and potentially influence KIAA0930 functions.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A inhibits histone deacetylases, impacting chromatin structure and possibly influencing KIAA0930 expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib inhibits the proteasome, potentially impacting protein degradation processes relevant to KIAA0930.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibitors of the PI3K/Akt pathway might impact signaling pathways relevant to KIAA0930.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibitors of the MAPK/ERK pathway might influence signaling pathways relevant to the function of KIAA0930.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine inhibits autophagy, potentially affecting KIAA0930 if it's involved in autophagic processes.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

Inhibiting NF-κB signaling might indirectly influence KIAA0930 activity if it's involved in related pathways.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Inhibitors of JAK/STAT signaling might indirectly influence KIAA0930 if it's involved in these pathways.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine is a DNA methyltransferase inhibitor, potentially affecting the epigenetic regulation of KIAA0930.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blockers might impact cellular signaling and processes relevant to KIAA0930.